Continuous hemofiltration dose calculation in a newborn patient with congenital heart disease and preoperative renal failure

International Journal of Artificial Organs

Volumn 30, Issue 3, 2007, Pages 258-261

  Ricci, Z ^a   Polito, A ^a   Giorni, C ^a   Di Chiara, L ^a   Ronco, C ^b   Picardo, S ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Continuous hemofiltration; Dialysis dose; Extracorporeal membrane oxygenation; Neonatal renal replacement therapy

Indexed keywords

BLOOD; DIALYSIS; DISEASES; OXYGENATION; PEDIATRICS;

CARDIOPULMONARY BYPASS; CONTINUOUS HEMOFILTRATION; CREATININE CONCENTRATION; DIALYSIS DOSE; EXTRACORPOREAL MEMBRANE OXYGENATION; HEMOFILTRATION; INTRA-OPERATIVE; NEONATAL RENAL REPLACEMENT THERAPY; RENAL FAILURE; RENAL REPLACEMENT THERAPIES;

RESPIRATORY THERAPY;

CREATININE; DIPYRIDAMOLE; FUROSEMIDE; HEPARIN;

ANURIA; ARTICLE; BIRTH WEIGHT; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CASE REPORT; CONTINUOUS HEMOFILTRATION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; EXTRACORPOREAL OXYGENATION; HEART SURGERY; HEART VENTRICLE FAILURE; HEMODILUTION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION TEST; KIDNEY POLYCYSTIC DISEASE; LUNG VEIN DRAINAGE ANOMALY; NEWBORN; NEWBORN INTENSIVE CARE; PERITONEAL DIALYSIS; PEROPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRESCRIPTION; STEADY STATE; THROMBOSIS; URINE VOLUME;

EID: 34248387375     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000312     Document Type: Article

References (12)

1. Ricci Z, Salvatori G, Bonello M, Bolgan I, D'Amico G, Dan M, Piccinni P, Ronco C. In vivo validation of the adequacy calculator for continuous renal replacement therapies. Crit Care 2005; 9: R266-73.
2. Goldstein SL, Currier H, Graf JM, et al. Outcome in children receiving continuous veno-venous hemofiltration. Pediatrics 2001; 107: 1309-12.
3. Goldstein SL, Somers MJ, Baum MA, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005; 67: 653-8.
4. Foland JA, Fortenberry JD, Warshaw BL, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med 2004; 32: 1771-6.
5. Laffey JG, Boylan JF, Cheng DC. The Systemic Inflammatory Response to Cardiac Surgery. Anesthesiology 2002; 97: 215-52.
6. Hauser GJ, Ben-Ari J, Colvin MP, Dalton HJ, Hertzog JH, Bearb M, et al. Interleukin-6 levels in serum and lung lavage fluid of children undergoing open heart surgery correlate with postoperative morbidity. Intensive Care Med 1998; 24: 481-6.
7. Wang MJ, Chiu IS, Hsu CM, Wang CM, Lin PL, Chang CI, et al. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg 1996; 61: 651-6.
8. Gaynor JW. Use of ultrafiltration during and after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg 2001; 122: 209-11.
9. Berdat PA, Eichenberger E, Ebell J, Pfammater JP, et al. Elimination of proinflammatory cytokines in pediatric cardiac surgery: Analysis of ultrafiltration method and filter type. J Thorac Cardiovasc Surg 2004; 127: 1688-96.
10. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous venovenous hemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26-30.
11. Brophy PD, Bunchman TE. References and overview for hemofiltration in pediatrics and adolescents. http://www.pcrrt.com/ Protocols%20PCRRT%2OZurich.pdf. Last access 8/25/2006.
12. Journois D, Israel-Biet D, Pouard P, Rolland B, Silvester W, Vouhe P, Safran D. High-volume, Zero-balanced Hemofiltration to Reduce Delayed Inflammatory Response to Cardiopulmonary Bypass in Children. Anesthesiology 1996; 85: 965-76.